Accelrys has released the latest version of its Discovery Studio life sciences modelling and simulation software. The release incorporates the first commercially available software for predicting protein-protein aggregation to advance biotherapeutics research. In addition, a major update to the software’s 3D-molecular ActiveX control enables researchers to display dynamic molecular visualisations in webpages, Microsoft Office applications and Microsoft SharePoint collaboration software.
Discovery Studio extends comprehensive modelling and simulation capabilities and knowledge from experts to the enterprise, combining collaborative science from Accelrys and leading academic and research institutions on a unified platform. The latest release includes the integration of a new algorithm licensed from Massachusetts Institute of Technology (MIT) that enables protein engineers to identify the size and location of regions on antibodies prone to aggregation and then predict mutations to improve formulation stability.
Discovery Studio 3.1 also features an updated Visualizer program with significant improvements to its 3D-molecular plug-in, Discovery Studio ActiveX Control. Now, using the ActiveX plug-in with Visualizer’s convenient 'storyboard' functionality, computational modelling experts can quickly and efficiently share interactive 3D visualisations of small molecules, proteins, nucleic acids, crystal structures and pharmacophore models with colleagues. Available as a free download with Discovery Studio Visualizer, the new ActiveX viewer enables scientists to insert dynamic molecular visualisations into webpages, slideshows and other presentation formats while also providing the flexibility to modify chemistry and data displays on-the-fly.
